LABORATORY INDICES OF COAGULATION AND INFLAMMATION IN PATIENTS WITH CORONAVIRUS INFECTION

The coronavirus pandemic has shown the global medical community that effective treatment of acute respiratory disease requires a lot of effort. Scientists and clinicians have managed to develop diagnostic and treatment algorithms, identify patients with a high risk of thrombotic complications and death. This required studying the pathogenesis of the disease, which is based on two conditions: coagulopathy and inflammation. Therefore, during the pandemic, laboratory studies of inflammation and blood clotting parameters were conducted to search for markers of thrombotic complications and markers that signal a deterioration in the condition. Expanding the boundaries of knowledge in laboratory research will allow for more advanced complex treatment and reduce potential complications of coronavirus infection.